What is the share price of EVOQ Remedies Ltd (EVOQ) today?
The share price of EVOQ as on 27th June 2025 is ₹5.44. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on EVOQ Remedies Ltd (EVOQ) share?
The past returns of EVOQ Remedies Ltd (EVOQ) share are- Past 1 week: 7.77%
- Past 1 month: 39.80%
- Past 3 months: 108.43%
- Past 6 months: -31.14%
- Past 1 year: -53.42%
- Past 3 years: -56.93%
- Past 5 years: -77.09%
What are the peers or stocks similar to EVOQ Remedies Ltd (EVOQ)?
The peers or stocks similar to EVOQ Remedies Ltd (EVOQ) include:What is the market cap of EVOQ Remedies Ltd (EVOQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of EVOQ Remedies Ltd (EVOQ) is ₹13.55 Cr as of 27th June 2025.What is the 52 week high and low of EVOQ Remedies Ltd (EVOQ) share?
The 52-week high of EVOQ Remedies Ltd (EVOQ) is ₹12.20 and the 52-week low is ₹2.11.What is the PE and PB ratio of EVOQ Remedies Ltd (EVOQ) stock?
The P/E (price-to-earnings) ratio of EVOQ Remedies Ltd (EVOQ) is 150.51. The P/B (price-to-book) ratio is 0.54.Which sector does EVOQ Remedies Ltd (EVOQ) belong to?
EVOQ Remedies Ltd (EVOQ) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy EVOQ Remedies Ltd (EVOQ) shares?
You can directly buy EVOQ Remedies Ltd (EVOQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
EVOQ Remedies Ltd
EVOQ Share Price
5.441.98% (-0.11)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
EVOQ Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
EVOQ Performance & Key Metrics
EVOQ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.34 | 6.56 | 0.83% |
EVOQ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
EVOQ Company Profile
EVOQ Remedies Limited is a pharmaceutical company engaged in marketing, trading, and distribution of a wide range of pharmaceutical formulation products including antibiotics and neurological drugs.
SUNPHARMA
PE Ratio
37.05
37.05
1Y Return
11.30%
11.30%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.02
23.02
1Y Return
1.45%
1.45%
Buy Reco %
74.19
74.19
TORNTPHARM
PE Ratio
59.18
59.18
1Y Return
20.55%
20.55%
Buy Reco %
76.00
76.00
DRREDDY
PE Ratio
19.14
19.14
1Y Return
4.32%
4.32%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
21.83
21.83
1Y Return
7.11%
7.11%
Buy Reco %
46.43
46.43
EVOQ Forecast
EVOQ Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
EVOQ
EVOQ
Income
Balance Sheet
Cash Flow
Annual Normal View
EVOQ Income Statement
EVOQ Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.25 | 9.07 | 10.02 | 16.78 | 26.41 | 6.31 | 14.17 | — | ||||||||
Raw Materials | 3.26 | 9.08 | 7.94 | 14.41 | 20.58 | 2.65 | 13.99 | — | ||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.03 | 0.01 | 0.05 | 0.01 | ||||||||||
| Employee Cost | 0.00 | 0.01 | 0.01 | 0.18 | 0.20 | 0.08 | ||||||||||
| Selling & Administrative Expenses | 0.01 | 0.01 | 1.16 | 1.32 | 4.50 | 3.98 | ||||||||||
| Operating & Other expenses | -0.03 | -0.03 | -0.07 | -0.59 | -1.21 | -1.03 | ||||||||||
EBITDA | 0.01 | 0.00 | 0.95 | 1.45 | 2.29 | 0.62 | 0.18 | — | ||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 | — | ||||||||
| PBIT | 0.01 | 0.00 | 0.95 | 1.45 | 2.29 | 0.61 | 0.13 | — | ||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| PBT | 0.01 | 0.00 | 0.95 | 1.45 | 2.29 | 0.61 | 0.13 | — | ||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.24 | 0.37 | 0.67 | 0.16 | 0.04 | — | ||||||||
| Net Income | 0.01 | 0.00 | 0.71 | 1.08 | 1.62 | 0.45 | 0.09 | — | ||||||||
| EPS | 0.14 | 0.00 | 10.00 | 1.51 | 1.19 | 0.33 | 0.04 | — | ||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EVOQ Company Updates
EVOQ Stock Peers
EVOQ Past Performance & Peer Comparison
EVOQ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| EVOQ Remedies Ltd | 150.51 | 0.54 | — |
| Sun Pharmaceutical Industries Ltd | 37.05 | 6.03 | 0.95% |
| Cipla Ltd | 23.02 | 3.88 | 1.06% |
| Torrent Pharmaceuticals Ltd | 59.18 | 16.49 | 0.96% |
EVOQ Stock Price Comparison
Compare EVOQ with any stock or ETFCompare EVOQ with any stock or ETF
EVOQ
EVOQ Holdings
EVOQ Shareholdings
EVOQ Promoter Holdings Trend
EVOQ Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
EVOQ Institutional Holdings Trend
EVOQ Institutional Holdings Trend
No institutional holdings trend are available
EVOQ Shareholding Pattern
EVOQ Shareholding Pattern
EVOQ Shareholding History
EVOQ Shareholding History
Foreign Institutions
smallcases containing EVOQ stock
smallcases containing EVOQ stock
Looks like this stock is not in any smallcase yet.
EVOQ Events
EVOQ Events
EVOQ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
EVOQ has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
EVOQ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
EVOQ has not given any dividends in last 5 years
EVOQ Dividends
EVOQ Dividends
Hmm, looks like data is unavailable here. Please come back after some timeEVOQ Stock News & Opinions
EVOQ Stock News & Opinions
Articles & Videos
Corporate
Evoq Remedies schedules EGM
Evoq Remedies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 June 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Evoq Remedies to conduct board meeting
Evoq Remedies will hold a meeting of the Board of Directors of the Company on 6 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Evoq Remedies to conduct board meeting
Evoq Remedies will hold a meeting of the Board of Directors of the Company on 29 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Evoq Remedies cancels board meeting
Evoq Remedies has cancelled the board meeting which was scheduled to be held on 25 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Evoq Remedies postpones board meeting
Evoq Remedies has postponed the meeting of the Board of Directors which was scheduled to be held on 18 April 2025. The meeting will now be held on 25 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Evoq Remedies schedules board meeting
Evoq Remedies will hold a meeting of the Board of Directors of the Company on 18 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Evoq Remedies to conduct board meeting
Evoq Remedies will hold a meeting of the Board of Directors of the Company on 10 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Evoq Remedies to convene AGM
Evoq Remedies announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 14.19%, vs industry avg of 9.02%
Over the last 5 years, market share stayed at 0%
Over the last 5 years, net income has grown at a yearly rate of 114.11%, vs industry avg of 15.29%